The advisory comes days after the ministry issued a separate direction to private satellite television channels to carry an anti-drug disclaimer during their pr...
MIB Anti-Drug Messaging Initiative
The Ministry of Information and Broadcasting (MIB) has intensified its efforts to promote anti-drug messaging across various media platforms, including OTT and television. This initiative follows advisory measures aimed at curbing drug-related content and promoting responsible messaging in the media.
Increased Regulatory Focus
The MIB's renewed focus on anti-drug messaging indicates a growing trend in media regulation aimed at promoting social responsibility.
Cross-Platform Messaging
The initiative's expansion from OTT to traditional TV reflects a comprehensive approach to media messaging.
Public Health Initiatives
This move aligns with broader public health initiatives aimed at combating drug abuse through media influence.
Content Compliance Requirements
Media platforms may face stricter compliance requirements as the MIB enforces these anti-drug messaging guidelines.
Industry Response
Media companies are likely to adapt their content strategies to align with the MIB's regulatory expectations.
MIB Advisory Issued
The MIB issued an advisory focusing on anti-drug messaging across OTT platforms.
Expansion to TV
Following the advisory, the MIB announced a mandatory anti-drug messaging push for television.
MIB Advisory Issued
The MIB issued an advisory focusing on anti-drug messaging across OTT platforms.
Expansion to TV
Following the advisory, the MIB announced a mandatory anti-drug messaging push for television.
MIB has specifically referred to general entertainment and non-news programmes, bringing a wide range of TV content within the scope of the public-awareness ini...
Get email updates on the latest developments in MIB Anti-Drug Messaging Initiative.
The Ministry of Information and Broadcasting (MIB) has intensified its efforts to promote anti-drug messaging across various media platforms, including OTT and television. This initiative follows advisory measures aimed at curbing drug-related content and promoting responsible messaging in the media.